CTMX Chart
See on advanced chart >
About
CytomX Therapeutics, Inc. was incorporated in Delaware in September 2010.The company is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on their Probody technology platform.The company's Probody...
Read More
- HighlightA leader in the field of conditionally activated oncology therapeutics
- ExchangeNASDAQ
- Listing Date10/08/2015
- Established DateInvalid Date
- Full-time Employees116
- Address151 Oyster Point Boulevard Suite 400 South San Francisco California 94080
- Tel1-650-5153185
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals
